Kimberly M. Murphy - 04 May 2022 Form 4 Insider Report for Blue Water Vaccines Inc. (ONCO)

Reporting relationship: Director
Issuer ticker: ONCO
Reported as of: 04 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2022, 10:43:39 UTC
Prior SEC filing: 17 Feb 2022
Next SEC filing: 09 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Murphy

Key filing fact

Kimberly M. Murphy filed Form 4 for Blue Water Vaccines Inc. (ONCO) on 27 May 2022.

Key facts

This page summarizes Kimberly M. Murphy's Form 4 filing for Blue Water Vaccines Inc. (ONCO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 May 2022, 10:43.

Change

Previous filing in this sequence was filed on 17 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BWV transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +4,655
Change %: +10%
Price: $0.000000
Shares after: 50,575
Date: 04 May 2022
Ownership: Direct
Underlying class: Common Stock, par value $0.00001 per share
Underlying amount: 4,655
Exercise price: $6.45
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock options (the "Options") were granted to Ms. Murphy on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023.